Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: The Ox who wrote (29257)	6/29/2021 10:40:39 AM
From: ItsAllCyclical	4 Recommendations Recommended By ajtj99 isopatch jpdunwell The Ox Read Replies (2) \| Respond to of 96710

You have a point, but people lived w/pandemics far, far worse than this one and life went on. There are far too many variants to shut down again. If we need to do things to lighten the stress on the healthcare system that's different, but for starters let's be open to all treatment regimens which could help and slow things down - ivermectin for one, mass vitamin D supplementation as another. Google, Facebook, Twitter and The WHO have been lying, distorting and omitting news from day 1.

To: The Ox who wrote (29257)	6/29/2021 10:42:55 AM
From: Qone0	3 Recommendations Recommended By ajtj99 The Ox towerdog Read Replies (1) \| Respond to of 96710

British physician Edward Jenner created the world’s first vaccine in 1796, against smallpox, by injecting a patient with pus from the sores of a milkmaid who had contracted a biologically related virus from cows. And for the last 200 years, researchers have created virtually all vaccines against viruses using that same method: giving people a form of the virus itself. Until 2020. More than 80 million Americans have been vaccinated against SARS-CoV-2 — the virus that causes COVID-19 — using the game-changing possibilities of mRNA technology. And while some people worry that the technology has been “rushed,” for more than 25 years university labs have been exploring the use of RNA, rather than viruses, to build the body’s immunity against diseases. Future vaccines and treatmentsMalaria. Tuberculosis. Hepatitis B. Cystic fibrosis. Those are just some of the diseases that researchers say could be the next focus of mRNA vaccines and treatments, aside from those already in human trials (HIV, rabies, and influenza). Scientists continue to explore mRNA treatments for several types of cancer. As explained by researchers at the University of Texas MD Anderson Cancer Center, mRNA instructs a patient’s cells to produce protein fragments based on a tumor’s genetic mutations, prompting the immune system to find other cells with the mutated proteins and attack the tumor cells that remain. “mRNA vaccines can be used to target almost any pathogen,” Cooke says. “You put in the code for a particular protein that stimulates an immune response. … It’s essentially unlimited.” https://www.aamc.org/news-insights/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases